Institut Claudius Regaud

Since it was founded, the Claudius Regaud Institute has made considerable contributions to advances in cancer research. Highly involved in fundamental research, it applies scientific discoveries to cancer diagnostics, treatments and prevention.

With 80 researchers and clinicians, the Claudius Regaud Institute continually carries out fundamental research and clinical innovations. The Institute carries out various studies though both national and international collaborations. Research activities involve multidisciplinary work and are related to cancer biology, epidemiology, radiation physics, radiotherapy and pharmacology.

Key research areas are:

• The fundamentals of Oncogenesis
• Pharmacology
• Hormone therapy for breast cancer
• Epidemiology
• Radiation physics
• Radiotherapy
• The clinical assessment of innovative therapies.